Pham Co Q D, Regal Randolph E, Bostwick Thomas R, Knauf Kara S
Faculty of Pharmacy, University of Montreal, Quebec, Canada.
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1261-6. doi: 10.1345/aph.1G703. Epub 2006 Jun 27.
Use of acid suppressant medications has increased in both frequency and breadth in recent years. Data have indicated that questionable use of acid suppressants for non-accepted indications is common.
To assess the indications and prevalence of acid suppressants used by inpatients on admission and at discharge.
A retrospective chart review of 213 patients admitted to the University of Michigan Hospital non-critical care general medical service was conducted. Relevant medical history, acid suppressant drug used, and indications were collected from both inpatient medical records and discharge medication lists.
Of the 213 patients reviewed, 29% were taking acid suppressants prior to admission, with 33% being proton pump inhibitors (PPIs). Once patients were admitted, acid suppressant use increased to 71% (152 of 213), with 84% PPIs, 11% histamine(2)-receptor antagonists, and 5% combination therapy. Based upon our criteria, only 10% (15 of 152) of those on acid suppressants were found to have an acceptable indication. In patients where any history of gastroesophageal reflux disorder (GERD) was deemed as an acceptable indication (32 other patients), 31% (47 of 152) had an acceptable indication. For the 137 patients with non-accepted indications, 29% had no discernable indication and 38% were prescribed acid suppressants for corticosteroid-associated or stress ulcer prophylaxis. A history of gastrointestinal bleeds or peptic ulcer disease of more than 3 months since initial diagnosis or documented exacerbation of symptoms comprised 8% of the population. The aforementioned group of GERD patients made up 23% of this group. Compared to the 29% of patients taking acid suppressants prior to admission, 54% (115 of 213) of patients were prescribed acid suppressants at discharge. If only recent exacerbations of GERD were deemed as long-term indications, 10% (12 of 115) of these patients were found to have accepted indications. If all GERDs were acceptable long-term indications, 27% (31 of 115) would have met criteria for acceptable outpatient use.
There is considerable excess usage of acid suppressants in both the inpatient and outpatient settings.
近年来,抑酸药物的使用频率和范围均有所增加。数据表明,将抑酸药物用于未被认可的适应症的情况很常见。
评估住院患者入院时和出院时使用抑酸药物的适应症及流行情况。
对密歇根大学医院非重症监护普通内科服务收治的213例患者进行回顾性病历审查。从住院病历和出院用药清单中收集相关病史、使用的抑酸药物及适应症。
在审查的213例患者中,29%在入院前服用抑酸药物,其中33%为质子泵抑制剂(PPI)。患者入院后,抑酸药物的使用率增至71%(213例中的152例),其中84%为PPI,11%为组胺-2受体拮抗剂,5%为联合治疗。根据我们的标准,在服用抑酸药物的患者中,仅10%(152例中的15例)有可接受的适应症。在任何有胃食管反流病(GERD)病史被视为可接受适应症的患者中(另外32例患者),31%(152例中的47例)有可接受的适应症。对于137例有不可接受适应症的患者,29%没有可辨别的适应症,38%因皮质类固醇相关或应激性溃疡预防而开具抑酸药物。有胃肠道出血病史或自初次诊断以来超过3个月的消化性溃疡病或有症状记录加重的患者占总人群的8%。上述GERD患者组占该组的23%。与入院前服用抑酸药物的29%患者相比,54%(213例中的115例)患者在出院时开具了抑酸药物。如果仅将近期GERD加重视为长期适应症,则这些患者中有10%(115例中的12例)有可接受的适应症。如果所有GERD均为可接受的长期适应症,则27%(115例中的31例)将符合门诊可接受使用的标准。
住院和门诊环境中抑酸药物的使用均存在大量过度使用的情况。